1446
G. Geen et al.
LETTER
(5) The experimental procedure for the preparation of ethyl 2-
Acknowledgement
azido-3-hydroxy-3-(2-chlorophenyl)propanoate (2a) is
representative:sodium (10.9 mg, 0.47 mmol, 0.1 eq) was
added to dry ethanol (6 mL), followed sequentially by ethyl
azidoacetate (0.550 g, 4.26 mmol, 1 eq) and benzaldehyde
(0.458 g, 4.32 mmol, 1 eq) and the reaction was stirred
overnight. after which time 2M HCl (5 mL) was added. The
solution was extracted with ethyl acetate (2 x10 mL) and the
combined extracts dried (MgSO4) and concentrated in vacuo
to yield the crude product as a yellow oil. After column
chromatography, acolourless oil (0.46 g, 46%) was obtained;
Rf 0.13(petrol:ether (7:1)); νmax (neat) / cm-1 3481, 2984,
2114, 1734; dH (400 MHz, CDCl3) 1.24 (3H, m), 3.98 &
4.09(total 1H, 2 x d, J 4.6 & 6.9), 4.24 (2H, m), 4.99 & 5.15
(total 1H, 2 x d,J 6.9 & 4.6), 7.35 (5H, m); dC (100 MHz,
CDCl3) 13.9, 62.1, 66.7, 67.6, 74.0, 74.4, 139.1, 128.8, 126.4,
126.2, 168.5;m/z (CI) (%) 51.03 (6), 79.05 (44), 107.04
We acknowledge the financial support of the EPSRC (studentship
to CJS), SBPharmaceuticals (CASE support to CJS and the Univer-
sity of Reading) the Nuffield Foundation, and ZENECA (for an
award from the Strategic Research Fund to JBS).
References and Notes
(1) For recent syntheses of such aminoacid derivatives,see:
Adams, Z.M.; Jackson, R.F.W.; Palmer, N.J.;Rami, H.K.;
Wythes, M.J.; J. Chem.Soc., Perkin Trans. 1, 1999, 937;
Enders, D.; Thomas, C.R.; Raabe, G.; Runsink, J.; Helv.
Chim. Acta, 1998, 81, 1329; Liu, J.Q.; Ito, S.; Dairi, T.; Itoh,
N.; Shimizu, S.; Yamada, H.;App. Microbiol. Biotech., 1998,
49, 702; deRooij, B.M.; Commandeur, J.N.M.; Hommes,
J.W.; Aalbers, T.; Groot,E.J.; Vermeulen, N.P.E.; Chem. Res.
Toxicology, 1998,11, 111; Liu, J.Q.; Dairi, T.; Itoh, N.;
Kataoka,M.; Shimizu, S.; Yamada, H.; Euro.J. Biochem.,
1998, 255, 220- 226; Carda, M.; Murga, J.; Rodriguez,
S.;Gonzalez, F.; Castillo, E.; Marco, J.A.; Tetrahedron:
Asymmetry, 1998, 9,1703; Liu, J.Q.; Ito, S.; Dairi, T.;Itoh, N.;
Kataoka, M.; Shimizu, S.; Yamada, H.; Appl.Env. Microbiol.,
1998, 64, 549; Talwar, R.; Jagath, J.R,Datta, A.; Prakash, V.;
Savithri, H.S.; Rao, N.A.; ActaBiochim. Polonica, 1997, 44,
679; Delle Fratte,S.; White, R.H.; Maras, B.; Bossa, F.;
Schirch, V.; J. Bacteriology,1997, 179, 7456; Jagath, J.R.;
Appaji Rao,N.; Savithri, H.S.; Biochem. J.,1997, 327, 877;
Lociuro, S.; Tavecchia, P.; Marzorati, E.; Landini, P.;
Goldstein,B.P.; Denaro, M.; Ciabatti, R.; J.Antibiot., 1997, 50,
344; Jagath, J.R.;Sharma, B.; Appaji Rao, N.; Savithri, H.S.;
J. Biol. Chem., 1997, 272,24355; Kataoka, M.; Ikemi, M.;
Morikawa, T.; Miyoshi, T.; Nishi, K.; Wada,M.; Yamada, H.;
Shimizu, S.; Euro.J. Biochem., 1997, 248, 385; Marco,J.A.;
Carda, M.; Murga, J.; Gonzalez, F.; Falomir, E.; Tetrahedron
Lett., 1997, 38,1841; Bycroft, M.; Herbert, R.B.; Ellames,
G.J.; J. Chem. Soc., Perkin Trans. 1, 1996, 2439; Streefland,
L.; Blandamer, M.J.; Engberts, J.B.F.N.; J. Am.Chem. Soc.,
1996, 118, 9539; Hawes,J.W.; Harper, E.T.; Crabb, D.W.;
Harris, R.A.; FEBS Lett.; 1996, 389, 263; Tavecchia, P.; Kurz,
M.; Colombo, L.;Bonfichi, R.; Selva, E.; Lociuro, S.;
Marzorati, E.; Ciabatti, R; Tetrahedron, 1996, 52, 8763;
Okuda, H.;Nagata, S.; Misono, H.; J. Biochem., 1996, 119,
690; Davis, F.A.; Liu, H.; Reddy, G.V.; Tetrahedron
Lett.,1996, 37, 5473; Hayashi, H.; Inoue, K.; Mizuguchi, H.;
Kagamiyama, H.;Biochem., 1996, 35, 6754; Takagi, H.;
Harima, A.; Euro.Neuropsychopharm., 1996, 6, 43.
+
(100),163.08 (28), 253.10 (14) [M++NH4 ]C11H13N3O3
requires 253.1301; found 253.1310. When tert-butyl esters
were employed, distilled tert-butanol replacedethanol in the
above procedure.
(6) The experimental procedure for the preparation ofethyl 2-(N-
BOC)-3-hydroxy-3-(2-chlorophenyl)propanoate (3b)
isrepresentative: palladium on carbon (0.052 g, 0.1 eq) was
stirred in ethylacetate (4 mL) under a hydrogen atmosphere
until hydrogen uptake ceased. Ethyl 2-azido-3-hydroxy-3-(2-
chlorophenyl)propanoate (0.500 g, 1.86 mmol) anddi-tert-
butyl dicarbonate (0.618 g, 2.83 mmol, 1.5 eq) were then
added simultaneously, as a solution in ethyl acetate (1 mL). To
the reaction wasthen added Celite¨ and the mixture was
filtered through a Celite¨pad; this pad was then washed with
ethyl acetate and the filtrate concentrated in vacuo, to yield the
crude product as an oil, which was purified by column
chromatography, to give (3b) as a colourless oil(0.393 g,
61%); Rf 0.43 (Petrol:ether (2:3)); νmax (neat) / cm-1 3441,
2981, 2935, 1730, 1716; dH (400MHz, CDCl3) 1.00-1.44 (3H,
br. m), 4.17 (2H, m), 4.63 (1H, d, J 9.5), 5.22 (1H, s),5.34 (1H,
d, J 9.5), 5.51-5.56 (1H, br. m), 7.13-7.46; dC (100 MHz,
CDCl3) 14.0, 14.4, 27.6, 28.3, 57.3, 58.2 (CNH), 61.9, 62.0,
71.0, 71.8, 85.5, 126.3, 126.8, 127.2, 128.1, 128.3,128.4,
128.5, 128.6, 129.1, 129.3, 129.4, 129.5, 132.0, 132.3,
137.5,137.8, 155.8, 156.0, 170.4, 171.1; m/z (CI) (%) 57.05
(26), 104.02 (59), 147.04 (100), 169.99 (9), 210.09
(20),243.94 (65), 288.02 (32), 344.13 (3) [M+H+]
C16H22ClNO5 requires 344.1265; found 344.1278. It should
be noted that, especially for (3g-3l), many of the 1H nmr
resonances were broadened by the presence of different
rotameric forms.
(2) Hemetsberger, H.; Knittel, D.; Monatsch. Chem., 1970, 101,
161; idem., ibid., 1969, 100, 1599.
(3) Murakami, Y; Watanabe, T; Suzuki, H; Kotake, N;Takahashi,
T; Toyonari, K; Ohno, M; Takase K; Suzuki, T; Kondo, K;
Chem. Pharm. Bull., 1997, 45, 1739.
Article Identifier:
1437-2096,E;1999,0,09,1444,1446,ftx,en;L09899ST.pdf
(4) Ko, S.Y.; J. Org. Chem.,1995, 60, 6250.
There is an erratum or addendum to this paper.
Synlett 1999, No. 9, 1444–1446 ISSN 0936-5214 © Thieme Stuttgart · New York